Boardroom Alpha
Meeting calendar
SHAZ · Annual meeting · Thursday, August 27, 2026

Sharonai Holdings Inc

2 nominees · 4 ballot items.

Ratify auditor (HoganTaylor LLP); elect Class I directors Alastair Cairns and Benjamin Adams; approve Second Amendment to 2025 Omnibus Equity Incentive Plan increasing share reserve by 1,200,000 and adding annual evergreen increases; approve issuance of Class A shares upon exercise of pre-funded warrants to Situational Awareness Partners LP in compliance with Nasdaq Rule 5635(b).

Market cap
$1.2B
1Y TSR
Board grade
C-
Record date
Jul 2, 2026
Filing
DEF 14A
Filed Jul 13, 2026 · DEF 14A
Proposals

On the ballot4

  1. 1

    Ratification of Auditor Appointment

    ManagementBoard: FOR

    Ratify appointment of HoganTaylor LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 (advisory vote).

  2. 2

    Election of Class I Directors

    ManagementBoard: FOR

    Elect Alastair Cairns and Benjamin Adams as Class I directors until the 2029 annual meeting.

  3. 3

    Approval of the Equity Plan Amendment Proposal

    ManagementBoard: FOR

    Approve Second Amendment to 2025 Omnibus Equity Incentive Plan to increase share reserve from 1,200,000 to 2,400,000 shares and add annual evergreen increases beginning January 1, 2027.

    More detail

    The proposal asks shareholders to approve a Second Amendment to the Company’s 2025 Omnibus Equity Incentive Plan, increasing the share reserve by 1,200,000 shares from 1,200,000 to 2,400,000 and adding an annual ‘evergreen’ increase mechanism beginning January 1, 2027. Management seeks approval to preserve the Company’s ability to grant equity awards — ISOs, nonstatutory options, SARs, RSUs and other stock-based awards — as part of compensation packages designed to attract, retain and motivate employees, directors and contractors. The board justifies the increase by citing historical burn rates, anticipated hiring and retention needs, and the need to align employee incentives with shareholder value. The amendment would add potential dilution of approximately 7.3% based on shares outstanding at the record date, increasing maximum potential dilution across all plans to about 14.4% — figures the company discloses and frames as reasonable. The inclusion of the evergreen provision ties future increases to a modest percentage (3%) of outstanding shares, limiting the size of automatic annual increases while simplifying administration. The board recommends FOR, noting stockholder approval is required for plan amendments and emphasizing governance controls including committee administration, limitations on counting reacquired shares, and clawback provisions tied to financial restatements. Potential investor concerns include dilution, executive compensation levels and the company’s historical high burn rate in 2025; the plan mitigates some concerns through limits on aggregate issuance, specific counting rules for reacquired shares, and board discretion on grants. Overall, the amendment is a typical management request to secure additional equity for incentive programs, with quantifiable dilution and standard governance safeguards; shareholders should weigh additional dilution against management’s retention and alignment rationale.

  4. 4

    Approval of the Pre-Funded Warrant Exercise Proposal

    ManagementBoard: FOR

    Approve issuance of Class A Ordinary Common Stock upon exercise of pre-funded warrants held by Situational Awareness Partners LP, to permit exercise beyond 19.99% beneficial ownership in compliance with Nasdaq Listing Rule 5635(b).

    More detail

    This management proposal requests shareholder approval to permit the full exercise of pre-funded warrants issued to Situational Awareness Partners LP in the June 2026 Private Placement. The pre-funded warrants would otherwise be subject to ownership limitations that cap exercise to prevent the holder from owning more than 19.99% of outstanding shares absent shareholder approval; approval is required under Nasdaq Listing Rule 5635(b) because full exercise would result in the holder owning approximately 21.32% of outstanding common shares, representing the largest ownership position. Management frames the vote as a technical compliance matter with Nasdaq rules to allow the private placement to be fully consummated and to enable the holder to exercise warrants at a nominal exercise price. The issuance could be dilutive if exercised in full (6,374,823 shares), reducing existing holders’ ownership percentages and potentially affecting market price and voting power; the company discloses these dilution effects and states that the shares would be restricted until registered or exempt from registration. The board recommends FOR, arguing that the transaction was negotiated at market terms and that shareholder approval is needed to comply with listing rules and avoid ownership limit obstacles. Key considerations for sophisticated investors include the degree of potential dilution, the strategic rationale for the investor’s position (not detailed in the filing), the impact on control or influence given the ~21% stake post-exercise, and any contractual restrictions on transfer and registration timing that could limit immediate market impact.

Director elections

Nominees on the ballot2

Ownership

Top institutional holders10

Latest 13F quarter
1Situational Awareness LP4.8%796,108$18M
2Situational Awareness Partners LP4.8%796,108$18M
3MILLENNIUM MANAGEMENT LLC4.2%698,646$16M
4Anson Funds Management LPActivist2.8%472,041$11M
5Two Seas Capital LP2.5%416,666$9M
6Galaxy Digital Inc.1.3%225,000$5M
7Alaska Wealth Advisors, LLC1.3%210,676$5M
8Regal Partners Ltd1.2%202,415$5M
9Hood River Capital Management LLC0.8%137,538$3M
10HAWK RIDGE CAPITAL MANAGEMENT LP0.7%122,155$3M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Sharonai Holdings Inc 2026 annual meeting?
Sharonai Holdings Inc (SHAZ) holds its 2026 annual shareholder meeting on Thursday, August 27, 2026.
What is the record date for the Sharonai Holdings Inc 2026 meeting?
The record date for the Sharonai Holdings Inc 2026 meeting is Thursday, July 2, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Sharonai Holdings Inc's 2026 meeting?
The board is presenting 2 director nominees at the Sharonai Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Sharonai Holdings Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Sharonai Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer